On August 28, Shanghai Heping Ophthalmology Hospital successfully hosted the acceptance ceremony for AIRDOC-B's ophthalmology PACS system and the launch ceremony for the fundus AI artificial intelligence platform. AIRDOC-B Vice President Zhao Lei and his delegation were invited to attend, witnessing this significant moment alongside the hospital's medical staff as Shanghai Heping Ophthalmology Hospital embarks on a new chapter in intelligent ophthalmic diagnosis and treatment.
Shanghai Heping Ophthalmology Hospital x AIRDOC-B: Joint Efforts to Create an Ophthalmology Informatization Benchmark
Prior to this ceremony, Shanghai Heping Ophthalmology Hospital had already achieved comprehensive integration of ophthalmic equipment, full-process management of imaging data, and optimization of the entire diagnostic and treatment service chain through the deployment of AIRDOC-B's PACS system, successfully addressing traditional challenges such as equipment silos, scattered imaging, low efficiency, and dormant data.
In his opening remarks, Zhang Haozhi, leader of Huaxia Eye Hospital Group, emphasized that Shanghai Heping Ophthalmology Hospital, serving as a key strategic pivot and central hub hospital for the group's layout in East China, has successfully deployed and excellently applied AIRDOC-B's PACS system. This represents not only a powerful practice of actively embracing transformation in the wave of medical digitalization and actively exploring the deep integration of medical artificial intelligence with informatization, but also demonstrates the hospital's firm determination to optimize diagnostic and treatment processes and improve diagnostic accuracy through technological innovation with patients at the center. This successful practice provides valuable experience with significant reference value and replicability for other hospitals within the group in medical technology applications and service model innovation, which will strongly promote the group's overall medical service capabilities to new heights.
Shanghai Heping Ophthalmology Hospital General Manager Hu Jianhui stated in his address that artificial intelligence technology is reshaping ophthalmic diagnosis and treatment models. The deployment of AIRDOC-B's PACS system and the construction of the fundus AI platform will greatly enhance the accuracy and efficiency of clinical diagnosis and treatment, providing doctors with more powerful decision-making support while offering patients higher quality and more convenient medical services.
Professor Guo Haike, Director of Shanghai Heping Ophthalmology Hospital, shared professional insights on the application requirements and prospects of the AIRDOC-B PACS project based on practical experience. He pointed out that the PACS system not only optimizes workflow but also provides strong support for clinical research. In the future, it can be further expanded to telemedicine consultation and hierarchical diagnosis and treatment scenarios, helping the hospital achieve coordination and sharing of regional medical resources.
Shanghai Heping Ophthalmology Hospital was awarded the title of "AIRDOC-B PACS System Demonstration Hospital"
Professor Guo Haike was appointed as "AIRDOC-B PACS Application Guidance Expert"
Attendees engaged in in-depth discussions on topics including the integrated application of AIRDOC-B PACS system and fundus AI technology, data security, and future cooperation directions, creating an enthusiastic atmosphere at the venue.
Launching Fundus AI Artificial Intelligence Platform to Usher in New Era of AI Eye Health Management
As artificial intelligence technology deeply integrates with the medical field, ophthalmic diagnosis and treatment models are experiencing unprecedented transformation. Another core highlight of this conference was the official launch of the "AIRDOC-B Fundus AI Artificial Intelligence Platform" at Shanghai Heping Ophthalmology Hospital. This initiative reflects Heping Hospital's continuous exploration in intelligent ophthalmic diagnosis and treatment, while providing practical reference for Huaxia Eye Hospital Group's layout in intelligent diagnosis and treatment and medical consortium fields.
AIRDOC-B presented on the theme "Application Scenarios of Fundus AI Artificial Intelligence in Ophthalmology Hospitals," demonstrating the enormous potential of artificial intelligence in auxiliary diagnosis of blinding eye diseases such as diabetic retinopathy and glaucoma. Moreover, its advantages are particularly evident in building regional medical consortiums and enhancing primary-level eye disease diagnosis capabilities and chronic disease prevention and control abilities. With its precise diagnostic capabilities and efficient data processing, this system can provide professional diagnostic support for primary medical institutions, facilitate information exchange between higher-level hospitals and primary hospitals in hierarchical diagnosis and treatment, enabling the true implementation of full-process hierarchical diagnosis and treatment closed loops, and achieving effective connection for patients' "upward referral" (from primary hospitals to higher-level hospitals) and "downward referral" (from higher-level hospitals back to primary hospitals).
Through deep learning algorithms, AI can analyze large volumes of fundus images and predict early signs of ophthalmic diseases such as glaucoma and diabetic retinopathy. This powerful predictive capability significantly improves screening efficiency and accuracy, making early intervention possible and effectively reducing vision damage caused by diseases.
The joint launch of the fundus AI artificial intelligence platform by both parties will help further improve the efficiency and accuracy of eye disease screening at Heping Hospital, making early intervention possible and effectively reducing vision damage caused by diseases. Zhang Haozhi, leader of Huaxia Eye Hospital Group, noted: "Leveraging AIRDOC-B's leading fundus AI technology will not only enhance the efficiency and accuracy of fundus disease diagnosis at Heping Hospital but also establish a positive demonstration effect within our ophthalmology hospital network ecosystem, allowing more patients to benefit from advanced AI ophthalmic diagnosis and treatment services."
In the future, AIRDOC-B will continue to fulfill its mission of "making health accessible everywhere" and deepen its AI-integrated diagnosis and treatment strategy. The company is committed to partnering with more industry allies to build an extensive and closely connected medical AI diagnosis and treatment ecosystem network, jointly promoting the deep integration of artificial intelligence technology with clinical practice, and contributing more solid AI strength to the development of global medical and health endeavors.